# Jolanta Małyszko

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jolanta-ma-yszko/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,781 |
| Field | Dialysis and Renal Disease Management |
| h-index | 63 |
| i10-index | 355 |
| Last Known Institution | Jagiellonian University |
| OpenAlex ID | https://openalex.org/A5085600917 |
| ORCID iD | 0000-0001-8701-8171 |
| Works | 1,082 |

## Researcher papers

Showing 12 of 15.

- [Chronic Kidney Disease and Coronary Artery Disease](https://scholariq.org/papers/chronic-kidney-disease-and-coronary-artery-disease/)
- [ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment](https://scholariq.org/papers/ispd-peritonitis-guideline-recommendations-2022-update-on-prevention-and/)
- [Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference](https://scholariq.org/papers/controversies-in-acute-kidney-injury-conclusions-from-a-kidney-disease-improving/)
- [Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference](https://scholariq.org/papers/harmonizing-acute-and-chronic-kidney-disease-definition-and-classification/)
- [Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/potassium-homeostasis-and-management-of-dyskalemia-in-kidney-diseases/)
- [Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/iron-management-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
- [May Measurement Month 2017: an analysis of blood pressure screening results worldwide](https://scholariq.org/papers/may-measurement-month-2017-an-analysis-of-blood-pressure-screening-results/)
- [Lipid management in patients with chronic kidney disease](https://scholariq.org/papers/lipid-management-in-patients-with-chronic-kidney-disease/)
- [Iron status in patients with chronic heart failure](https://scholariq.org/papers/iron-status-in-patients-with-chronic-heart-failure/)
- [May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension](https://scholariq.org/papers/may-measurement-month-2018-a-pragmatic-global-screening-campaign-to-raise/)
- [Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference](https://scholariq.org/papers/controversies-in-optimal-anemia-management-conclusions-from-a-kidney-disease/)
- [SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA](https://scholariq.org/papers/sglt-2-inhibitors-and-glp-1-receptor-agonists-for-nephroprotection-and/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Researcher university

- [Jagiellonian University](https://scholariq.org/institutions/jagiellonian-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.